Hosted on MSN5mon
European shortages of Novo Nordisk's Ozempic to continue through Q4said the European Medicines Agency in a statement. These shortages are expected to persist throughout the fourth quarter of 2024, making it difficult for healthcare providers and patients relying ...
Sanofi is to create a European company focused ... the essential building blocks of medicines that are causing concerns amid fears of shortages due to the coronavirus outbreak in China.
Europeans are being warned of the dangers of counterfeit medications after police squads across the continent reported ...
Authorities in many countries are scrambling for solutions to mounting shortages of medicine. Will any of them work?
The Swedish Medical Products Agency is pushing for the creation of a state-run pharmaceutical production company to deal with shortages of critical medicines. The Swedish Medical Products Agency ...
This aims to allow the agency to better monitor when medicines are running out. It would also improve Sweden’s reporting of shortages to the European Medicines Agency (EMA), the report says.
"The problem of shortages is not going to go away tomorrow. And it is not just a regulatory issue: it needs input from all stakeholders and concerted actions from all stakeholders,” she said. The EU ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results